Structure Therapeutics In... (GPCR)
NASDAQ: GPCR
· Real-Time Price · USD
19.81
1.28 (6.91%)
At close: Aug 15, 2025, 1:22 PM
Structure Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -178.99M | -143.37M | -122.53M | -110.68M | -100.56M | -97.81M | -89.79M | -76.99M | -65.55M | -56.22M | -51.32M | -39.46M | -27.04M | -13.09M | -13.36K |
Depreciation & Amortization | 1.1M | 1.04M | 1.43M | 1.44M | 1.25M | 1.09M | 503.92K | 295K | 292K | 277K | 277K | 205.07K | 129.07K | 70.07K | 66.00 |
Stock-Based Compensation | 25.28M | 21.97M | 18.79M | 15.06M | 10.9M | 8.4M | 8.19M | 6.72M | 5.49M | 4.43M | 2.51M | 1.89M | 1.26M | 620.94K | 937.00 |
Other Working Capital | 7.28M | 2.14M | -343.77K | 1.11M | -1.15M | 1.62M | 7.85M | 6.18M | 204K | -3.31M | 815K | 1.14M | 1.98M | 371.44K | 439.00 |
Other Non-Cash Items | -23.66M | -18.92M | -15.16M | -10.57M | -4.59M | -1.75M | -977.2K | -710K | -893K | -885K | -558K | 254.06K | 161.06K | 65.06K | 65.00 |
Deferred Income Tax | n/a | n/a | n/a | -1.27M | -2.93M | -4.58M | -4.58M | -2.9M | -1.51M | n/a | 6.01K | -403.99K | -123.99K | 6.01K | 4.00 |
Change in Working Capital | 13.17M | 4.33M | 2.98M | 6.24M | -4.71M | 3.49M | 6.98M | 3.8M | 2.47M | -514K | 2.97M | 3.41M | 1.99M | -1.19M | 1.52K |
Operating Cash Flow | -162.95M | -134.76M | -116.55M | -102M | -102.86M | -93.38M | -79.67M | -69.78M | -59.71M | -52.91M | -46.12M | -34.1M | -23.62M | -13.53M | -10.76K |
Capital Expenditures | -1.25M | -1.44M | -1.29M | -2.43M | -2.57M | -2.33M | -2.17M | -1.08M | -334K | -90K | -155K | -84.12K | -12.12K | -65.12K | -120 |
Cash Acquisitions | n/a | n/a | n/a | -37.57K | -68.52K | n/a | n/a | 27.16K | 74.69K | 22.3K | 22.3K | 32.71K | 16.13K | n/a | n/a |
Purchase of Investments | -592.37M | -786.76M | -702.52M | -807.27M | -567.02M | -259.55M | -417.77M | -189.96M | -221.01M | -271.9M | -123.45M | -114.27M | -68.28M | -41.65M | n/a |
Sales Maturities Of Investments | 520.5M | 461.91M | 344.9M | 236.67M | 216M | 43.82M | 151.46M | 113.78M | 97.3M | 200.58M | 61.5M | 41.9M | 12.5M | 2M | 1.2K |
Other Investing Acitivies | 275.07K | 66.00 | 1.65K | 1.65K | -242.47K | -35.99K | -86.59K | -76.17K | -123.71K | -71.32K | -61.95K | -71.17K | -54.58K | -38.45K | 1.2K |
Investing Cash Flow | -72.84M | -326.29M | -358.91M | -573.03M | -353.86M | -218.06M | -268.49M | -77.26M | -124.04M | -71.41M | -62.11M | -72.45M | -55.79M | -39.72M | 1.08K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.99K | -5.99K | -5.99K | -5.99K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.18M | 79K | -28K | -19.01M | -17.78M | -17.49M | -20.77M | -2.71M | -3.44M | 27.89M | 29.01M | 29.21M | 29.47M | -1.56M | -115K |
Financial Cash Flow | 1.18M | 514.68M | 514.57M | 795.93M | 797.16M | 282.85M | 451.87M | 169.59M | 168.85M | 200.19M | 29.01M | 29.33M | 29.59M | -1.45M | -115 |
Net Cash Flow | -229.5M | 54.3M | 39.73M | 121.5M | 341.05M | -28.66M | 103.7M | 22.54M | -14.9M | 75.87M | -79.21M | -77.22M | -49.83M | -54.69M | -9.79K |
Free Cash Flow | -164.2M | -136.23M | -117.87M | -104.46M | -105.45M | -95.72M | -81.84M | -70.87M | -60.04M | -53M | -46.27M | -34.19M | -23.64M | -13.59M | -10.88K |